MED19 antibody (N-Term)
Quick Overview for MED19 antibody (N-Term) (ABIN2786281)
Target
See all MED19 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Sequence
- MRELPGSTEL TGSTNLITHY NLEQAYNKFC GKKVKEKLSN FLPDLPGMID
-
Predicted Reactivity
- Cow: 100%, Dog: 100%, Guinea Pig: 93%, Horse: 100%, Human: 100%, Mouse: 100%, Pig: 100%, Rabbit: 100%, Rat: 100%
-
Characteristics
- This is a rabbit polyclonal antibody against Med19. It was validated on Western Blot.
-
Purification
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide corresponding to a region of Rat
-
-
-
-
Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
-
Comment
-
Antigen size: 244 AA
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
-
: "A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion." in: Oncogene, Vol. 36, Issue 4, pp. 446-457, (2016) (PubMed).
-
: "A large-scale RNAi screen identifies LCMR1 as a critical regulator of Tspan8-mediated melanoma invasion." in: Oncogene, Vol. 36, Issue 4, pp. 446-457, (2016) (PubMed).
-
- MED19 (Mediator Complex Subunit 19 (MED19))
-
Alternative Name
- Med19
-
Background
-
The function remains unknown.
Alias Symbols: RGD1311926, Med19
Protein Size: 244 -
Molecular Weight
- 27 kDa
-
Gene ID
- 311165
-
NCBI Accession
- NM_001107741, NP_001101211
-
UniProt
- D3ZAP1
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha
Target
-